Higher values indicate better insulin sensitivity. This metric helps distinguish between insulin resistance and beta cell dysfunction as causes of hyperglycemia. It guides treatment choices - those with low sensitivity benefit from sensitizers like metformin, while those with low beta cell function may need secretagogues.
Higher values indicate better insulin sensitivity. This metric helps distinguish between insulin resistance and beta cell dysfunction as causes of hyperglycemia. It guides treatment choices - those with low sensitivity benefit from sensitizers like metformin, while those with low beta cell function may need secretagogues.
HOMA2-%S measures insulin sensitivity as a percentage of a reference population, indicating how effectively insulin lowers blood glucose.
High HOMA2-%S levels above the standard range may indicate an underlying health condition that warrants further evaluation.
Low HOMA2-%S levels below the standard range may indicate an underlying health condition that warrants further evaluation.
HOMA2-%S measures insulin sensitivity as a percentage of a reference population, indicating how effectively insulin lowers blood glucose.
Normal and optimal HOMA2-%S ranges can vary by sex, age, and lab methodology. Review your result with a qualified clinician for personalized interpretation.
Higher values indicate better insulin sensitivity. This metric helps distinguish between insulin resistance and beta cell dysfunction as causes of hyperglycemia. It guides treatment choices - those with low sensitivity benefit from sensitizers like metformin, while those with low beta cell function may need secretagogues.
Low insulin sensitivity: Weight gain, fatigue, difficulty losing weight, elevated triglycerides, low HDL, elevated blood pressure, increased waist circumference.
Low HOMA2-%S: Obesity (especially visceral), sedentary lifestyle, high carbohydrate diet, chronic inflammation, sleep deprivation, stress, genetic factors.
HOMA2-%S can be ordered through Vitals Vault without a doctor referral, then completed at CLIA-certified Quest Diagnostics locations nationwide. After checkout, you receive clear draw instructions, digital requisition details, and a structured report that explains whether your result is in standard range, optimal range, or needs follow-up review.
Start by identifying the root cause, then use targeted nutrition, training, sleep, stress, and follow-up retesting to verify improvement. HOMA2-%S should be optimized with a personalized plan, not guesswork.
You should speak with a clinician if HOMA2-%S is significantly outside the reference range, trending in the wrong direction across repeat tests, or accompanied by symptoms like fatigue, chest discomfort, dizziness, weight change, or persistent inflammation signs. Immediate medical care is important for severe symptoms, not just abnormal numbers in isolation.
A practical retesting cadence for HOMA2-%S is every 8 to 12 weeks after major lifestyle, nutrition, or medication changes, and every 3 to 6 months for stable long-term tracking. Faster cadence is useful when values are clearly abnormal, while maintenance cadence helps confirm durability once results stabilize.
You can compare Essential ($99), Advanced ($199), and Max ($399) plans during checkout to confirm HOMA2-%S inclusion before purchasing. If HOMA2-%S is not in your selected tier, you can upgrade plans or add targeted testing so your panel matches your goals, symptoms, and retesting strategy.
HOMA2-%S is included in our comprehensive biomarker panels, processed at CLIA-certified Quest Diagnostics locations nationwide.
Foundation for a full basic health picture.
Deeper metabolic and nutritional insights.
Comprehensive testing for lifelong health.
Medical Disclaimer: This content is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions about a medical condition or treatment. Do not disregard professional medical advice or delay seeking it because of information presented here.